The transcription factor E4F1 coordinates CHK1-dependent checkpoint and mitochondrial functions

Area of Science:

• Molecular Biology
• Cancer Research
• Cellular Metabolism

Background:

• Transcriptional regulators like MYC and p53 impact both tumorigenesis and cellular metabolism.
• The interplay between cell cycle regulation and metabolic pathways is critical in cancer progression.
• The role of multifunctional proteins in coordinating these processes remains an area of active investigation.

Purpose of the Study:

• To investigate the role of the multifunctional protein E4F1 in regulating cellular metabolism and cell cycle checkpoints.
• To determine the impact of E4F1 inactivation on p53-deficient cancer cells.
• To explore potential therapeutic strategies targeting E4F1-controlled pathways.

Main Methods:

• Gene expression analysis to identify E4F1-regulated genes involved in mitochondrial function and cell cycle.
• Functional assays to assess the effects of E4F1 inactivation on cell viability, DNA damage, and reactive oxygen species (ROS) production.
• Metabolic profiling to evaluate energy stress and pyrimidine synthesis inhibition.

Main Results:

• E4F1 directly controls genes involved in mitochondrial function and cell-cycle checkpoints, including Chek1.
• Inactivation of E4F1 in p53-deficient cells leads to CHK1-dependent checkpoint deficiency and severe mitochondrial dysfunction.
• This results in increased ROS, energy stress, inhibited pyrimidine synthesis, oxidative damage, and DNA damage, ultimately causing cell death.

Conclusions:

• E4F1 is essential for the survival of p53-deficient transformed cells by coordinating mitochondrial function and cell-cycle checkpoints.
• Targeting both mitochondria and CHK1 presents a promising therapeutic strategy for selectively eliminating p53-deficient cancer cells.